Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK).
Betticher DC, Ratschiller D, Hsu Schmitz SF, von Rohr A, Hess U, Zulian G, Wernli M, Tichelli A, Tobler A, Fey MF, Cerny T. Betticher DC, et al. Among authors: von rohr a. Ann Oncol. 1998 Jul;9(7):721-6. doi: 10.1023/a:1008273131598. Ann Oncol. 1998. PMID: 9739437 Free article. Clinical Trial.
Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL).
Betticher DC, Martinelli G, Radford JA, Kaufmann M, Dyer MJ, Kaiser U, Aulitzky WE, Beck J, von Rohr A, Kovascovics T, Cogliatti SB, Cina S, Maibach R, Cerny T, Linch DC. Betticher DC, et al. Among authors: von rohr a. Ann Oncol. 2006 Oct;17(10):1546-52. doi: 10.1093/annonc/mdl153. Epub 2006 Aug 3. Ann Oncol. 2006. PMID: 16888080 Free article. Clinical Trial.
Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.
von Rohr A, Schmitz SF, Tichelli A, Hess U, Piguet D, Wernli M, Frickhofen N, Konwalinka G, Zulian G, Ghielmini M, Rufener B, Racine C, Fey MF, Cerny T, Betticher D, Tobler A; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. von Rohr A, et al. Ann Oncol. 2002 Oct;13(10):1641-9. doi: 10.1093/annonc/mdf272. Ann Oncol. 2002. PMID: 12377655 Free article. Clinical Trial.
Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK).
Betticher DC, Hsu Schmitz SF, Ratschiller D, von Rohr A, Egger T, Pugin P, Stalder M, Hess U, Fey MF, Cerny T. Betticher DC, et al. Among authors: von rohr a. Br J Haematol. 1997 Nov;99(2):358-63. doi: 10.1046/j.1365-2141.1997.3923206.x. Br J Haematol. 1997. PMID: 9375754 Free article. Clinical Trial.
25 results